Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 15/20 | 0.38 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.34 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.34 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.34 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.34 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.34 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.34 |
| ▸ | SCARB1 | Q8WTV0 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25515547 | 0.88 | CNR2 (0.40) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25517063 | 0.81 | CNR2 (0.44) | CNR2CNR1HPGD | |
| SCHEMBL25516687 | 0.81 | CNR2 (0.44) | CNR2CNR1HPGD | |
| SCHEMBL23802420 | 0.81 | CNR2 (0.39) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL23802421 | 0.79 | CNR2 (0.38) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25517137 | 0.79 | CNR2 (0.41) | CNR2CNR1ALDH1A1HPGD | |
| SCHEMBL25516849 | 0.78 | CNR2 (0.43) | CNR2SCARB1CNR1ALDH1A1HPGD | |
| SCHEMBL25520089 | 0.77 | CNR2 (0.39) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25520088 | 0.77 | CNR2 (0.39) | CNR2PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL25515550 | 0.77 | CNR2 (0.44) | CNR2PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CNR2 663/4885PSEN1 3112/4885PSEN2 3041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.